- Clinical Trials
- January 2024
- 60 Pages
Global
From €1448EUR$1,500USD£1,242GBP
- Book
- August 2019
- 416 Pages
Acetylcholinesterase (AChE) is an enzyme that catalyzes the hydrolysis of the neurotransmitter acetylcholine. It is found in the nervous system of both vertebrates and invertebrates, and is essential for normal functioning of the nervous system. AChE inhibitors are used in the treatment of Alzheimer's disease, myasthenia gravis, and other neurological disorders. AChE inhibitors are also used as insecticides, as they interfere with the nervous system of insects.
The AChE market is a rapidly growing market, driven by the increasing prevalence of neurological disorders and the growing demand for insecticides. The market is expected to grow at a steady rate in the coming years, due to the increasing demand for AChE inhibitors.
Some of the major companies in the AChE market include Merck & Co., Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, and Bayer AG. Show Less Read more